Novel bispecific antibody 4224 shows in vivo efficacy in tumors expressing high levels of EpCAM Oct. 10, 2019
First patient enrolled in phase II study of bavituximab plus pembrolizumab in gastric cancer Oct. 10, 2019
Prokarium receives funding from Wellcome for clinical development of lead vaccine program Oct. 10, 2019
RSS